CDK2-IN-55

CDK2-IN-55 is a potent and highly selective cyclin-dependent kinase 2 (CDK2) inhibitor (IC50 = 15 nM) . It disrupts the cell cycle machinery to specifically induce G1/S phase arrest in cancer cells, showing excellent anti-clonogenic and anti-proliferative activities in various gastrointestinal tumor models.